BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27332823)

  • 1. Whole Blood Gene Expression Differentiates between Atrial Fibrillation and Sinus Rhythm after Cardioversion.
    Raman K; Aeschbacher S; Bossard M; Hochgruber T; Zimmermann AJ; Kaufmann BA; Pumpol K; Rickenbacker P; Paré G; Conen D
    PLoS One; 2016; 11(6):e0157550. PubMed ID: 27332823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation.
    Möllmann H; Weber M; Elsässer A; Nef H; Dill T; Rixe J; Schmitt J; Sperzel J; Hamm CW
    Circ J; 2008 Jun; 72(6):921-5. PubMed ID: 18503217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion.
    Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Arnesen H; Smith P
    Int J Cardiol; 2009 Jan; 131(2):234-9. PubMed ID: 18201783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP predicts maintenance of sinus rhythm after electrical cardioversion.
    Andersson J; Rosenqvist M; Tornvall P; Boman K
    Thromb Res; 2015 Feb; 135(2):289-91. PubMed ID: 25481046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion.
    Shin DI; Jaekel K; Schley P; Sause A; Müller M; Fueth R; Scheffold T; Guelker H; Horlitz M
    Z Kardiol; 2005 Dec; 94(12):795-800. PubMed ID: 16382379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between brain natriuretic peptides and recurrence of atrial fibrillation after successful direct current cardioversion: a meta-analysis.
    Zografos T; Maniotis C; Katsivas A; Katritsis D
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1530-7. PubMed ID: 25113607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Goudis CA; Maliaraki NE; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE
    Am J Cardiol; 2010 Jan; 105(1):90-4. PubMed ID: 20102897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.
    Buob A; Jung J; Siaplaouras S; Neuberger HR; Mewis C
    Pacing Clin Electrophysiol; 2006 Jun; 29(6):559-63. PubMed ID: 16784419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma NT-proANP in patients with persistent atrial fibrillation who underwent successful cardioversion.
    Bartkowiak R; Wozakowska-Kapłon B; Janiszewska G
    Kardiol Pol; 2010 Jan; 68(1):48-54. PubMed ID: 20131188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of electrical cardioversion on troponine I and brain natriuretic peptide (NT-proBNP) levels in patients with persistent atrial fibrillation/flutter].
    Puljević M; Nevajda B; Sicaja M; Puljević D; Milicić D
    Lijec Vjesn; 2008; 130(7-8):175-8. PubMed ID: 18979903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV
    Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of Natriuretic Peptides with Left Atrial Structure and Function within 1 Month after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation.
    Karaliute R; Jureviciute J; Jurgaityte J; Stanaitiene G; Mizariene V; Kazakevicius T; Urboniene D; Kavoliuniene A
    Biomed Res Int; 2019; 2019():7636195. PubMed ID: 31008112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation.
    Wozakowska-Kaplon B; Bartkowiak R; Janiszewska G
    Pacing Clin Electrophysiol; 2010 May; 33(5):561-5. PubMed ID: 20059712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillation.
    Meyre PB; Aeschbacher S; Blum S; Voellmin G; Kastner PM; Hennings E; Kaufmann BA; Kühne M; Osswald S; Conen D
    Sci Rep; 2022 Jan; 12(1):1680. PubMed ID: 35102265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).
    Darkner S; Goetze JP; Chen X; Henningsen K; Pehrson S; Svendsen JH
    Am J Cardiol; 2017 Oct; 120(8):1309-1315. PubMed ID: 28865890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.